Membranous nephropathy in children: clinical presentation and therapeutic approach
Open Access
- 12 November 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 25 (8), 1419-1428
- https://doi.org/10.1007/s00467-009-1324-5
Abstract
The approach to the pediatric patient with membranous nephropathy (MN) can be challenging to the practitioner. The clinical presentation of the child with this histologic entity usually involves some degree of proteinuria ranging from persistent, subnephrotic-ranged proteinuria to overt nephrotic syndrome. Patients often have accompanying microscopic hematuria and may have azotemia or mild hypertension. Children presenting with nephrotic syndrome are often steroid resistant; as such, their biopsy for steroid-resistant nephrotic syndrome results in the diagnosis of MN. The practitioner treating MN in the pediatric patient must weigh the risks of immunosuppressive therapy against the benefits. In general, the child with subnephrotic proteinuria and normal renal function can likely be treated conservatively with angiotensin blockade (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) without the need for immunosuppressive therapy. Those with nephrotic syndrome are usually treated with steroids initially and often followed by alkylating agents (cyclophosphamide or chlorambucil). Calcineurin inhibitors may also be useful, but the relapse rate after their discontinuation remains high. The absence of controlled studies in children with MN makes treatment recommendations difficult, but until they are available, using the patient’s clinical presentation and risk of disease progression appears to be the most prudent approach.Keywords
This publication has 58 references indexed in Scilit:
- Rituximab Therapy for Membranous NephropathyClinical Journal of the American Society of Nephrology, 2009
- Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2008
- Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcomeBMC Nephrology, 2007
- IgA deficiency and membranous glomerulonephritis presenting as nephrotic syndromePediatric Nephrology, 2005
- A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous NephropathyNew England Journal of Medicine, 1989
- A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1989
- Idiopathic membranous nephropathy in childrenThe Journal of Pediatrics, 1982
- Idiopathic membranous glomerulopathy in Canadian children: A clinicopathologic studyThe Journal of Pediatrics, 1982
- A Controlled Study of Short-Term Prednisone Treatment in Adults with Membranous NephropathyNew England Journal of Medicine, 1979
- Extramembranous glomerulonephritis inchildren: Report of 50 casesThe Journal of Pediatrics, 1973